Daniel Tasse

Insider Reports History

Location
C/O Ikaria, Inc., 6 State Route 173, Clinton, NJ
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Tasse:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Director Common Stock 19.1K $152K $7.97 May 30, 2025 Direct
DBV Technologies S.A. CHIEF EXECUTIVE OFFICER, Director Ordinary Shares 17.1K $14.2K $0.83 Mar 8, 2024 Direct
DBV Technologies S.A. CHIEF EXECUTIVE OFFICER, Director Employee Stock Option (right to buy) 813K Dec 4, 2024 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 39.8K May 30, 2025 Direct
REGENXBIO Inc. Director Stock Options (Right to Buy) 24.5K May 31, 2024 Direct

Insider Reports Filed by Daniel Tasse

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. May 30, 2025 2 $0 4 Jun 3, 2025 Director
DBVT DBV Technologies S.A. Dec 4, 2024 1 $0 4 Dec 5, 2024 CHIEF EXECUTIVE OFFICER, Director
RGNX REGENXBIO Inc. May 31, 2024 2 $0 4 Jun 4, 2024 Director
DBVT DBV Technologies S.A. Mar 8, 2024 1 $14.2K 4 Mar 11, 2024 CHIEF EXECUTIVE OFFICER, Director
DBVT DBV Technologies S.A. Nov 20, 2023 1 $0 4 Nov 22, 2023 Chief Executive Officer, Director
RGNX REGENXBIO Inc. Jun 2, 2023 2 $0 4 Jun 6, 2023 Director
DBVT DBV Technologies S.A. Nov 21, 2022 1 $0 4 Aug 14, 2023 Chief Executive Officer, Director
RGNX REGENXBIO Inc. Jun 3, 2022 2 $0 4 Jun 7, 2022 Director
DBVT DBV Technologies S.A. Nov 22, 2021 1 $0 4 Nov 24, 2021 Chief Executive Officer, Director
RGNX REGENXBIO Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director